• All sections
  • C - Chemistrymetallurgy
  • C07D - Heterocyclic compounds
  • C07D 295/13 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain

Patent holdings for IPC class C07D 295/13

Total number of patents in this class: 553

10-year publication summary

37
30
36
30
28
38
38
35
63
17
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026

Principal owners for this class

Owner
All patents
This class
Acuitas Therapeutics Inc.
128
22
Massachusetts Institute of Technology
10196
13
The Regents of the University of California
20534
11
The Trustees of the University of Pennsylvania
4403
11
Beam Therapeutics Inc.
266
9
Dow Global Technologies LLC
10770
8
The Board of Trustees of the University of Illinois
2740
8
Modernatx, Inc.
1278
7
South China University of Technology
1867
7
Recurium IP Holdings, LLC
126
7
Centre National de La Recherche Scientifique
10865
6
The Salk Institute for Biological Studies
451
6
Albert Einstein College of Medicine, Inc.
591
5
PTC Therapeutics, Inc.
473
5
University College Cardiff Consultants Limited
260
5
The Procter & Gamble Company
21905
4
BASF SE
21113
4
Allergan, Inc.
2214
4
Abbvie Inc.
1843
4
Arbutus Biopharma Corporation
163
4
Other owners 403